Jardiance Wins CV Prevention Indication
(MedPage Today) -- FDA approves claim that diabetes drug reduces cardiovascular death risk
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Cardiology | Cardiovascular | Diabetes | Empagliflozin | Endocrinology | Heart | International Medicine & Public Health | Jardiance